AMPs (Associated Molecular Patterns) are the cPNI diagnostic framework (Metamodel 4) that categorizes approximately 25 distinct inflammatory trigger pathways, each with unique molecular signatures, mediators, and treatment targets. They explain why the same downstream mechanism (insulin resistance, endotoxemia, cortisol resistance) requires completely different treatments in different patients β because the upstream AMP determines the pathway. AMPs bridge the gap between ~1 billion risk factors and ~17 universal mechanisms, making personalized treatment possible.
Think of chronic disease as a flooded basement. The flood (the mechanism β insulin resistance, low-grade inflammation) is the same in every house. But the source of the water is different: in one house, it's a burst pipe (PAMP β bacterial infection); in another, a cracked foundation letting in groundwater (DAMP β tissue damage); in another, someone left the bathtub running upstairs (EAMP β chronic emotional stress); in another, the roof is leaking (Nutritional-AMP β gluten damage); and in yet another, toxic sludge is seeping through the walls (TAMP β pesticides, heavy metals).
The water damage looks identical in all five basements β ruined drywall, mold, warped floors. But if you don't find the source, bailing out the water is pointless. And worse: the fix for a burst pipe (turn off the water main, replace the pipe) is completely useless for a leaking roof (patch the shingles, improve drainage). You can spend years mopping the floor (treating the mechanism) without ever solving the problem.
In cPNI, the AMPs are the leak sources. The downstream mechanisms are the flooded basement. Treatment must address the source, not just the flood. That's why two patients with identical insulin resistance need different interventions β one needs to fix their gut (endotoxemia from PAMPs), the other needs trauma therapy (EAMP), and the third needs to remove glyphosate exposure (TAMP).
And here's the critical twist: some AMPs are unkillable leaks β imagine a concrete wall that permanently weeps water because the foundation material itself is porous. That's oxidised LDL, titanium implants, nanoparticles β the immune system cannot degrade them, so it keeps sending repair crews forever, creating permanent low-grade inflammation. The immune system develops "anti-stop mechanisms" because the job never finishes.
graph TD
A["~1 billion risk factors<br/>(genes, diet, stress, toxins, microbiome)"] --> B["~25 AMPs<br/>(molecular pathways)"]
B --> C["~17 mechanisms<br/>(adaptive responses)"]
C --> D["Chronic disease<br/>(text determines which)"]
B --> E["PAMP: LPS β TLR4 β NF-ΞΊB"]
B --> F["DAMP: HMGB1 β RAGE β inflammation"]
B --> G["EAMP: Cortisol β GR dysfunction"]
B --> H["SAMP: NOX2 β oxidative stress"]
B --> I["Nutritional-AMP: Gliadin β tight junction loss"]
E --> J[Low-grade inflammation]
F --> J
G --> J
H --> J
I --> J
J --> K["Endotoxemia + Hyperpermeability"]
K --> L[Insulin & Leptin Resistance]
L --> M[Cytokine Resistance]
M --> N[Loss of Flexibility]
N --> D
style A fill:#e1f5ff
style B fill:#fff4e1
style C fill:#ffe1e1
style D fill:#f0f0f0
style J fill:#ffcccc
Each of the 7 consciousness-linked AMPs maps to the 5 plus 2 metamodel:
1. PAMP (Pathogen-Associated Molecular Pattern)
2. DAMP (Damage-Associated Molecular Pattern)
- Molecular trigger: HMGB1, extracellular ATP, uric acid, heat shock proteins, cell-free DNA, hyaluronan fragments
- Receptor pathway: HMGB1 β RAGE / TLR4 β NF-ΞΊB; ATP β P2X7 purinergic receptors β inflammasome (NLRP3) activation β caspase-1 β IL-1Ξ² maturation
- Downstream: Sterile inflammation, tissue repair signals, fibrosis (chronic DAMP exposure)
- Consciousness: Physiological
- Example: Tumor progression releases DAMPs β pro-tumor inflammation
3. EAMP (Emotional-Associated Molecular Pattern)
4. CAMP (Cognitive-Associated Molecular Pattern)
5. SAMP (Social-Associated Molecular Pattern)
- Molecular trigger: Loneliness, social defeat, discrimination, rejection, ostracism
- Receptor pathway: Anterior cingulate cortex (ACC) + insula β sympathetic nervous system β NOX2 (NADPH oxidase) activation β reactive oxygen species (ROS) β lipid peroxidation β blood-brain barrier breakdown β neuroinflammation
- Specific mechanism: Social defeat stress β Ξ²-adrenergic receptor signaling β NOX2 in brain endothelial cells β oxidative damage
- Downstream: Brain tissue damage (NOX2 is uniquely neurotoxic), depression, cognitive decline
- Consciousness: Social
- EXAM KEY: Social defeat is the worst AMP β more damaging than emotional or cognitive stress (Module 4)
6. Sex-AMP (Sexual-Associated Molecular Pattern)
- Molecular trigger: Sexual dysfunction, touch deprivation, sexual trauma
- Receptor pathway: Oxytocin pathway disruption β loss of oxytocin receptor (OXTR) signaling β impaired parasympathetic nervous system activation β loss of anti-inflammatory vagal tone
- Downstream: Loss of pair-bonding stress buffering, immune dysregulation
- Consciousness: Sexual
7. Transgenerational AMP (TRAMP)
- Molecular trigger: Ancestral trauma (war, famine, abuse, emigration, family secrets)
- Epigenetic pathway: Glucocorticoid receptor hypermethylation (NR3C1 gene) β FKBP5 demethylation β enhanced GR sensitivity β exaggerated HPA axis responses
- Additional targets: IL-1 receptor methylation, ACE gene methylation
- Downstream: Inherited vulnerability to stress, altered immune set points
- Consciousness: Transgenerational
- Mechanism: Germ cell reprogramming escape + placental/lactational transfer
Fructose-AMP
- Mechanism: Fructose β hepatic metabolism β ATP β ADP β AMP β adenosine deaminase β inosine monophosphate β xanthine oxidase β uric acid (>5.5 mg/dL)
- Downstream: Uric acid crystals β NLRP3 inflammasome β IL-1Ξ² β insulin resistance (hepatic)
- Sources: High-fructose corn syrup, fruit juice, alcohol (ethanol β acetaldehyde β hepatic ATP depletion)
Nutritional-AMP (Food/Dietary)
Toxin-AMP (TAMP)
- Triggers: Pesticides (5-7 nm particle size β crosses blood-brain barrier), glyphosate, heavy metals (lead, mercury, cadmium), dioxins, plastics (BPA, phthalates), nanoparticles
- Mechanism: Glyphosate β shikimate pathway inhibition (gut bacteria) β aromatic amino acid deficiency (tryptophan, phenylalanine, tyrosine) β serotonin/dopamine synthesis failure
- Dioxins β aryl hydrocarbon receptor (AhR) β CYP1A1 induction β estrogen metabolism disruption
- Heavy metals β mitochondrial Complex I/III inhibition β ROS β mtDNA damage β mtDAMPs
- Downstream: Multi-system toxicity, neuroinflammation, endocrine disruption
Microbiome-AMP
- Triggers: C-section delivery, no breastfeeding, antibiotics, processed diet
- Mechanism: Loss of Bifidobacteria, Akkermansia muciniphila, Faecalibacterium prausnitzii β dysbiosis β loss of SCFA production (butyrate <20 mM fecal concentration) β colonocyte starvation β barrier dysfunction
- Additional: Dysbiosis β CTRA (Conserved Transcriptional Response to Adversity) activation β pro-inflammatory gene expression (IL-6, IL-8, TNF-Ξ± upregulation; interferon response downregulation)
- Downstream: Endotoxemia, adipose tissue dysfunction
Light-AMP
- Trigger: Blue light exposure (460-480 nm) at night
- Mechanism: Blue light β melanopsin (retinal ganglion cells) β suprachiasmatic nucleus (SCN) β melatonin suppression (pineal AANAT enzyme inhibition)
- Downstream: Loss of melatonin's antioxidant function (scavenges hydroxyl radicals) + immunomodulation β circadian disruption β clock gene desynchronization (CLOCK, BMAL1, PER, CRY)
- Result: Metabolic dysfunction, cancer risk (shift workers)
HITM-AMP (Human Immunogenic Titanium Material)
- Triggers: Titanium implants (dental, orthopedic), stents, silicone implants
- Mechanism: Titanium particles β macrophage phagocytosis β frustrated phagocytosis (cannot digest metal) β perpetual IL-1Ξ², TNF-Ξ± secretion β chronic foreign body response
- Key point: >1000 immunogenic molecules released from titanium corrosion
- Downstream: Unkillable AMP β permanent low-grade inflammation
graph LR
A[Unkillable AMP] --> B[Immune activation]
B --> C[Phagocytosis attempt]
C --> D{Can degrade?}
D -->|No| E[Frustrated phagocytosis]
E --> F[Cell death / particle release]
F --> B
D -->|Normal antigen| G[Resolution]
E --> H[Anti-stop mechanisms]
H --> I[Override resolution signals]
I --> J[Permanent LGI]
style A fill:#ffcccc
style E fill:#ff9999
style H fill:#ff6666
style J fill:#ff3333
Why LGI Never Resolves:
The immune system has thousands of stop signals (resolvins, protectins, maresins, lipoxins, IL-10, TGF-Ξ²). In normal acute inflammation:
In unkillable AMP scenarios:
- Oxidized LDL: Macrophages phagocytose ox-LDL β cannot metabolize cholesterol β become foam cells β die β release ox-LDL β next macrophage repeats β atherosclerosis
- Titanium/metal implants: Macrophages attempt phagocytosis β cannot degrade metal β chronic frustrated phagocytosis β permanent cytokine secretion
- Nanoparticles (5-100 nm): Too small to degrade, too synthetic to metabolize β persistent ROS generation
- Microplastics: Cannot be broken down β chronic foreign body response
Anti-stop mechanism development:
- Chronic AMP exposure β SOCS3 upregulation (blocks IL-10 receptor) β resistance to own stop signals
- Inflammasome priming β reduced threshold for activation
- Epigenetic changes: histone methylation at IL-6, TNF-Ξ± promoters β sustained transcription despite resolution signals
Result: "Permanent immune activation searching for a solution that doesn't exist" (Leo Pruimboom, Module 4)
Multiple AMPs (food, toxins, stress, sitting, light, etc.)
β
[Low-grade inflammation](/en/low-grade-inflammation) (IL-6 >3 pg/mL, CRP >3 mg/L)
β
[Endotoxemia](/en/concepts/endotoxemia.md) (LPS >50 pg/mL) + [Intestinal permeability](/en/concepts/intestinal-permeability.md) (zonulin >50 ng/mL)
β
[Insulin resistance](/en/insulin-resistance) (HOMA-IR >2.5) + [Leptin resistance](/en/leptin-resistance) (leptin >10 ng/mL with obesity)
β
[Cytokine resistance](/en/concepts/cytokine-resistance.md) ([SOCS3](/en/concepts/socs3.md)-mediated receptor desensitization)
β
Loss of metabolic/immunological/neuroendocrine flexibility
β
Chronic disease (genetics = text determines which disease)
EXAM KEY: The text (genetic predisposition) chooses the disease phenotype; the context (AMP constellation) produces the pathological conflict.
The Primus Movens Method:
- Current presentation shows multiple downstream mechanisms (e.g., insulin resistance, cortisol resistance, elevated CRP)
- Patient timeline traces backward to find the first molecular pathway disrupted
- Example timeline:
- Today: Type 2 diabetes, depression, chronic pain
- 5 years ago: Weight gain started, fatigue began
- 10 years ago: Divorce (EAMP), started shift work (Light-AMP + Sleep-AMP)
- 15 years ago: Antibiotic course for pneumonia (Microbiome-AMP)
- Primus movens: Antibiotic-induced dysbiosis β endotoxemia β all downstream mechanisms
Treatment Logic:
- Remove/reduce the AMP β mechanism resolves spontaneously
- Example: Patient with insulin resistance from Fructose-AMP:
- Ineffective: Metformin alone (treats mechanism, not cause)
- Effective: Eliminate fructose sources + support uric acid clearance β uric acid normalizes β inflammasome deactivates β insulin sensitivity returns
- Example: Patient with insulin resistance from EAMP:
- Ineffective: Diet and exercise alone (wrong AMP)
- Effective: Trauma therapy (EMDR, somatic experiencing) β HPA axis normalization β cortisol resistance resolves β insulin signaling restores
Metamodel 1 (Text-Context): AMPs are the "context" layer β they define which environmental factors activate which pathways in which genetic background.
Metamodel 3 (Selfish Brain): AMPs determine which selfish system becomes dominant:
- PAMP/DAMP β Selfish immune system dominance
- EAMP/SAMP β Selfish brain dominance (immune suppression for survival)
- Nutritional-AMP β Metabolic system battles immune system
Metamodel 4 (Inflammation & Disease): AMPs are Metamodel 4 β the complete diagnostic architecture.
Metamodel 5 (Bonding System): SAMP, Sex-AMP, TRAMP directly damage bonding system β loss of social buffering β vulnerability to all other AMPs.
| AMP Type |
Key Biomarker |
Threshold |
Clinical Implication |
| PAMP |
LPS (endotoxin) |
>50 pg/mL |
Active gut barrier dysfunction |
| PAMP |
Calprotectin (fecal) |
>50 ΞΌg/g |
Intestinal inflammation |
| DAMP |
HMGB1 (serum) |
>5 ng/mL |
Tissue damage, sterile inflammation |
| EAMP |
Cortisol awakening response |
Blunted (<2.5 nmol/L increase) |
HPA axis exhaustion |
| EAMP |
Evening cortisol |
>150 nmol/L at 23:00 |
HPA dysregulation |
| Fructose-AMP |
Uric acid |
>5.5 mg/dL |
Metabolic syndrome risk |
| Nutritional-AMP |
Zonulin |
>50 ng/mL |
Intestinal permeability |
| Nutritional-AMP |
Anti-gliadin IgG |
>20 U/mL |
Gluten sensitivity |
| TAMP |
Glyphosate (urine) |
>1 ΞΌg/L |
Chronic exposure |
| Light-AMP |
Melatonin (nighttime) |
<30 pg/mL |
Circadian disruption |
| Microbiome-AMP |
Butyrate (fecal) |
<20 mM |
SCFA deficiency |
| Microbiome-AMP |
Akkermansia abundance |
<1% of total bacteria |
Barrier dysfunction risk |
| All AMPs |
IL-6 |
>3 pg/mL |
Low-grade inflammation |
| All AMPs |
hs-CRP |
>3 mg/L |
Cardiovascular risk |
| All AMPs |
HOMA-IR |
>2.5 |
Insulin resistance |
Multiple AMP Constellations (Most Common):
- Metabolic syndrome patient: Nutritional-AMP + Fructose-AMP + Lifestyle-AMP + Microbiome-AMP
- Autoimmune patient: TRAMP + EAMP + Nutritional-AMP + TAMP
- Chronic fatigue patient: EAMP + SAMP + Microbiome-AMP + Light-AMP + Sleep-AMP
- Cancer survivor: DAMP (tumor debris) + TAMP (chemo) + EAMP (diagnosis trauma) + HITM-AMP (port/reconstruction)
Treatment Prioritization:
- Identify all active AMPs
- Remove unkillable AMPs first (HITM-AMP β consider implant removal if feasible)
- Address consciousness-linked AMPs with therapy (EAMP, SAMP, TRAMP require psychological intervention)
- Optimize lifestyle AMPs (easiest wins β diet, light, sleep)
- Support microbiome restoration (slow process, requires other AMPs controlled first)
- ~25 AMPs bridge ~1 billion risk factors to ~17 universal mechanisms β this is the core of cPNI diagnosis
- Social defeat (SAMP) is the worst AMP β NOX2-mediated oxidative stress causes direct brain damage, more severe than emotional or cognitive stress (Module 4)
- Unkillable AMPs (oxidized LDL, titanium, nanoparticles, plastics, silicone) cause permanent LGI by forcing the immune system to develop "anti-stop mechanisms"
- 95% of chronic diseases share the same downstream mechanisms β the AMP constellation determines which disease manifests and how to treat it
- The primus movens (first mover) AMP is found by backward timeline analysis β today's presentation hides the original trigger
- No single AMP alone causes chronic disease β it's always the combination that overwhelms homeostatic capacity
- Titanium implants release >1,000 immunogenic molecules β dental implants, hip prostheses, and cardiac stents are common HITM-AMP sources
- Fructose-AMP works via ATP depletion β uric acid >5.5 mg/dL β NLRP3 inflammasome activation β IL-1Ξ² β insulin resistance
- Gluten (Nutritional-AMP) triggers zonulin release via MyD88/CXCR3 pathway β tight junction loss β LPS translocation (endotoxemia pathway)
- Blue light (Light-AMP) is far more suppressive of melatonin than red light β 460-480 nm wavelength is the critical range
- TRAMP epigenetics: FKBP5 demethylation + glucocorticoid receptor hypermethylation creates inherited stress vulnerability
- Glyphosate (TAMP) crosses the blood-brain barrier at 5-7 nm particle size, disrupts shikimate pathway (gut bacteria) β aromatic amino acid deficiency
- CTRA (Conserved Transcriptional Response to Adversity) is activated by Microbiome-AMP β pro-inflammatory transcription profile (IL-6β, TNF-Ξ±β, IFN responseβ)
- Each consciousness in the 5+2 metamodel maps to one core AMP β physiological (PAMP/DAMP), emotional (EAMP), cognitive (CAMP), social (SAMP), sexual (Sex-AMP), transgenerational (TRAMP)
- Treatment matching: Wrong AMP intervention = no resolution (e.g., diet alone cannot fix EAMP-driven insulin resistance; therapy alone cannot fix Fructose-AMP)
- 5 plus 2 metamodel β each consciousness level maps to a specific AMP category (physiologicalβPAMP/DAMP, emotionalβEAMP, socialβSAMP)
- Text-Context Model β AMPs are the "context" layer that determines which "text" (genetic predisposition) activates disease
- Selfish Brain β AMP load determines which selfish system dominates (immune vs brain vs metabolic)
- low-grade inflammation β all AMPs converge on LGI as the universal downstream mechanism (IL-6 >3 pg/mL, CRP >3 mg/L)
- cytokine resistance β chronic AMP exposure β SOCS3 upregulation β resistance to IL-6, leptin, insulin signaling
- endotoxemia β Nutritional-AMP, Microbiome-AMP, and gut-affecting AMPs β LPS translocation >50 pg/mL β TLR4 activation
- insulin resistance β universal mechanism from multiple AMPs (Fructose-AMP via uric acid, EAMP via cortisol, Nutritional-AMP via inflammation, TAMP via mitochondrial damage)
- leptin resistance β metabolic permission system failure from chronic AMP load β loss of satiety signaling
- cortisol resistance β EAMP/CAMP chronic activation β glucocorticoid receptor downregulation β loss of anti-inflammatory cortisol effect
- SOCS3 β universal cytokine brake hijacked by chronic AMP exposure β creates selective resistance to stop signals
- inflammatory resolution β unkillable AMPs block this process by forcing "anti-stop mechanisms" (override of SPM, IL-10, TGF-Ξ² signals)
- PAMP β classical pathogen patterns (LPS, peptidoglycan, flagellin) β TLR β NF-ΞΊB β acute inflammation
- DAMP β damage patterns (HMGB1, ATP, uric acid) β sterile inflammation via RAGE, P2X7, NLRP3
- EAMP β emotional stress β HPA axis β cortisol/catecholamines β glucocorticoid resistance pathway
- SAMP β social stress β NOX2 activation β oxidative brain damage (worst AMP per Module 4)
- CAMP β cognitive stress β prefrontal-HPA-SNS activation β immune suppression then rebound activation
- Transgenerational AMP β inherited epigenetic patterns (FKBP5, NR3C1 methylation) β stress axis hypersensitivity
- HITM-AMP β unkillable foreign materials (titanium, silicone) β permanent frustrated phagocytosis β chronic IL-1Ξ²/TNF-Ξ±
- sickness behaviour β PAMP/DAMP activation β IL-1Ξ², IL-6, TNF-Ξ± β hypothalamic response β fatigue, anorexia, social withdrawal
- intestinal permeability β Nutritional-AMP (gluten) β zonulin β tight junction disassembly β barrier failure
- TLR4 β primary receptor for PAMPs (LPS) and some DAMPs β MyD88 adaptor β NF-ΞΊB β pro-inflammatory cytokines
- NF-ΞΊB β master inflammatory transcription factor activated by most AMP pathways β IL-6, TNF-Ξ±, IL-1Ξ² gene expression
- NLRP3 inflammasome β activated by DAMPs (uric acid, ATP, ROS) and PAMPs β caspase-1 β IL-1Ξ² maturation
- HPA axis β EAMP/CAMP primary pathway β CRH β ACTH β cortisol β widespread metabolic/immune effects
- sympathetic nervous system β activated by EAMP, CAMP, SAMP β norepinephrine β Ξ²2-adrenergic receptor β immune modulation
- NOX2 β SAMP-specific oxidative stress generator in brain endothelial cells β blood-brain barrier breakdown β neuroinflammation
- osteocalcin β EAMP disrupts osteocalcin pathway (cortisol inhibits osteoblasts) β metabolic dysfunction
- gluten β primary Nutritional-AMP trigger β gliadin + WGA β zonulin release β intestinal permeability β systemic inflammation
- fructose β Fructose-AMP pathway β ATP depletion β uric acid production β NLRP3 activation β metabolic syndrome
- uric acid β Fructose-AMP mediator, also a DAMP β >5.5 mg/dL threshold β inflammasome priming β insulin resistance
- glyphosate β TAMP example β shikimate pathway disruption β tryptophan/phenylalanine/tyrosine deficiency β neurotransmitter synthesis failure
- pesticides β TAMP category β 5-7 nm particles cross blood-brain barrier β neuroinflammation, neurodegenerative risk
- zonulin β Nutritional-AMP mediator β tight junction modulation β >50 ng/mL indicates intestinal permeability
- melatonin β Light-AMP disrupts via blue light β loss of antioxidant/immunomodulatory function β circadian desynchronization
- Akkermansia muciniphila β Microbiome-AMP keystone species β mucin degradation β SCFA production β barrier integrity
- butyrate β Microbiome-AMP product β colonocyte energy source β <20 mM fecal indicates dysbiosis β barrier failure
- CTRA β Microbiome-AMP activates Conserved Transcriptional Response to Adversity β pro-inflammatory gene signature
- FKBP5 β TRAMP epigenetic target β demethylation increases HPA axis sensitivity β stress vulnerability inheritance
- glucocorticoid receptor β EAMP/TRAMP target β chronic cortisol β receptor downregulation β cortisol resistance
- oxidised LDL β unkillable AMP example β macrophage foam cells β atherosclerosis progression despite treatment
- blood-brain barrier β SAMP (NOX2-mediated) and TAMP (pesticide) damage β neuroinflammation access β cognitive decline
- IL-6 β universal LGI marker from all AMPs β >3 pg/mL indicates active low-grade inflammation
- TNF-Ξ± β early pro-inflammatory cytokine from most AMP pathways β NF-ΞΊB activation β amplification loop
- IL-1Ξ² β NLRP3 inflammasome product (DAMP pathway) β fever, acute phase response, insulin resistance
- CRP β downstream acute phase protein marker β >3 mg/L hs-CRP indicates cardiovascular risk from chronic AMP load
- resolvins β specialized pro-resolving mediators blocked by unkillable AMPs β resolution failure β chronic LGI
- microbiome β Microbiome-AMP target and regulator β dysbiosis amplifies PAMP load β multiple pathway activation
- Module 1 (Introduction) β AMP framework introduced as Metamodel 4, diagnostic architecture overview
- Module 4 (The Immune System) β unkillable AMPs, anti-stop mechanisms, social AMP as worst AMP (NOX2 pathway), inflammasome activation, PAMP/DAMP detailed mechanisms
- Module 8 (Diagnosis) β complete AMP inventory (~25 AMPs), 17 mechanisms mapping, primus movens methodology, clinical application protocols, timeline analysis